Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis CHENGDU, China, Feb. 8, 2025 /PRNewswire/ — KeyMed Biosciences (HKEX: 02162) today… CISION PRNewswireFebruary 8, 2025
Press ReleaseBrook Gaming Introduces Wingman FGC 2: Breaking Limits, Redefining Control! TAIPEI, Feb. 8, 2025 /PRNewswire/ — With the PlayStation 5 Pro taking… CISION PRNewswireFebruary 8, 2025
ZK International Postpones Shareholder Call WENZHOU, China, Feb. 8, 2025 /PRNewswire/ — ZK International Group Co., Ltd.… CISION PRNewswireFebruary 8, 2025
EPWK HOLDINGS LTD. Announces Closing of Initial Public Offering XIAMEN, China, Feb. 8, 2025 /PRNewswire/ — EPWK HOLDINGS LTD. (the "Company")… CISION PRNewswireFebruary 7, 2025
SunCar Technology Group Announces Share Repurchase Program NEW YORK, Feb. 7, 2025 /PRNewswire/ — SunCar Technology Group Inc. ("SunCar"… CISION PRNewswireFebruary 7, 2025
Press ReleaseDuelNow Launches $DNOW Token Delivering Membership Rewards for Users LISBON, Portugal, Feb. 7, 2025 /PRNewswire/ — DuelNow – the trailblazing sports prediction… CISION PRNewswireFebruary 7, 2025
Press ReleaseGrey/Ven Appoints Ilana Kugel as Creative Director for Womenswear Announces NYFW Runway Show and Launch of Luxury Handbag and Accessories NEW… CISION PRNewswireFebruary 7, 2025
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 7th NEW YORK, Feb. 7, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireFebruary 7, 2025
